Quick Dispatch:
Your tirzepatide trial obesity without diabetes SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide trial obesity without diabetes SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes ships.
Need Help?
Questions about tirzepatide trial obesity without diabetes SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide trial obesity without diabetes SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes in your area.
New drug tirzepatide delivers significant and long-lasting weight loss
27.05
A trial emulation in Nature Medicine shows that treatment with semaglutide and tirzepatide showed similar levels of benefit on cardiovascular outcomes in people at elevated cardiovascular risk with obesity and diabetes. Link
27.97
Tirzepatide led to greater real-world weight loss than semaglutide for adults with obesity
28.35
Tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial
27.69
Presented at #ECO2025: In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference. Full trial results:
28.28
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
29.94
Perspectives on weight control in diabetes – Tirzepatide
20.84
